Comment Submissions - Announcement of the Carcinogen Identification Committee Meeting Scheduled for December 5, 2019, Notice of Availability of Hazard Identification Materials for Acetaminophen and Notice of Public Comment Period
This comment period was open from 09/20/2019 until 11/04/2019.
Notice
Announcement of the Carcinogen Identification Committee Meeting Scheduled for December 5, 2019, Notice of Availability of Hazard Identification Materials for Acetaminophen and Notice of Public Comment PeriodComments
California Life Sciences Association (CLSA)
clsa_-_oehha_-_prop_65_acetaminophen_letter_11-1-2019_-_revised_final.pdf
clsa_-_oehha_-_prop_65_acetaminophen_letter_11-1-2019_-_revised_final.pdf
Consumer Healthcare Products Association
integrated_response_document_cic_04_nov_2019_chpa_final.pdf
integrated_response_document_cic_04_nov_2019_chpa_final.pdf
Consumer Healthcare Products Association
chpa_qsp_modeling_moa_cic_supplementary_materials_03_nov_2019_final.pdf
chpa_qsp_modeling_moa_cic_supplementary_materials_03_nov_2019_final.pdf
Health, medical, patient, and consumer advocates
110419_stakeholder_letter_urging_no_listing_for_apap.pdf
110419_stakeholder_letter_urging_no_listing_for_apap.pdf
Protecting Access to Pain Relief (PAPR) Coalition Comments Re: CIC Acetaminophen
papr_coalition_letter_re_prop_65_apap_11.1.19.pdf
papr_coalition_letter_re_prop_65_apap_11.1.19.pdf